Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             89 results found
no title author magazine year volume issue page(s) type
1 Addressing Gaps in Management of Homozygous Familial Hypercholesterolemia: The Impacts of Continuing Medical Education that Includes Patients Drexel, Carole

17 4S p. e3
article
2 ⁎ A Genome-First Approach to Identify Carriers of Familial Hypercholesterolemia Causing variants Mami, Salma

17 4S p. e24-e25
article
3 A Machine-Learning Algorithm using Claims Data to Identify Patients with Homozygous Familial Hypercholesterolemia (HoFH) Gu, Jing

17 4S p. e24
article
4 † Angiographic Outcomes When Target Goals of Lipid Therapy Are Not Met Feeman Jr, William E.

17 4S p. e11-e12
article
5 † A Randomized Study to Compare LDL-C-Lowering Effects of Inclisiran with Usual Care vs Usual Care Alone in Patients with Recent Hospitalization for an Acute Coronary Syndrome: Rationale and Design of the VICTORION-INCEPTION trial Anderson, Jeffrey L

17 4S p. e55-e56
article
6 A Rare Dyslipidemia: Review of Diagnosis and Therapeutics in Management of Familial Chylomicronemia Syndrome (FCS) Javed, Fiza

17 4S p. e53-e54
article
7 Association between Niacin ER Use, Safety, and Cardiovascular Events: A Single Center Experience Tabani, Halima Mushtaq

17 4S p. e48-e49
article
8 Association of Physical Activity and Dietary Quality with Weight, Ectopic Fat, and Insulin Resistance in South Asian Men and Women: The MASALA Study Ponir, Cynthia Azam

17 4S p. e49-e50
article
9 Atrial Fibrillation Outcome in Patients with Familiar Hypercholesterolemia Amoah, Joseph Kofi

17 4S p. e30-e31
article
10 Bempedoic Acid and Cardiovascular Outcomes in Statin Intolerant Patients At High Cardiovascular Risk: CLEAR OUTCOME Cho, Leslie

17 4S p. e62
article
11 Beneficial Effect of Statins in Chronic Kidney Disease Vorla, Mounica

17 4S p. e39-e40
article
12 CAC Scoring as an Index for Subclinical Carotid Atherosclerosis Kommavarapu, Harshavardhini

17 4S p. e36
article
13 Cardioprotection from a Silent Syndrome: Effect of Gilbert's Syndrome on Cardiovascular Disease in Patients with Familial Hypercholesteremia Brown, Debra

17 4S p. e29
article
14 Case Report - Lysosomal Acid Lipase Deficiency - A Rare Cardiometabolic Disease and a NAFLD Mimic Vedamurthy, Deepak

17 4S p. e21-e22
article
15 Characteristics Associated with Inclisiran Initiation in Outpatient Physician Clinics Ballantyne, Christie M

17 4S p. e33-e34
article
16 Characteristics of Individuals with Dyslipidemia Referred for Genetic Screening for Genetic Lipid Disorders Vartak, Natasha

17 4S p. e22-e23
article
17 Characteristics of Patients Initiating Inclisiran in the Real World: A Retrospective Analysis of a US Database Niu, Xiaoli

17 4S p. e57-e58
article
18 † Cholesterol Efflux Capacity in Patients with or without Type 2 Diabetes Mellitus: A Meta-Analysis Chi, Gerald

17 4S p. e33
article
19 Clinical Vignette - Keto Diet-Induced Dyslipidemia and Lean Mass Hyper-Responders Vedamurthy, Deepak

17 4S p. e7-e8
article
20 ⁎ Closing The Gap: A Quality Improvement Initiative to Educate House Staff and Faculty on Guideline Directed Lipid Lowering Therapy Weintraub, Spencer Frederick

17 4S p. e2
article
21 CME Activity Highlights the Improvement in Clinician's Knowledge and Competence about Treatment Choices for LDL-C Lowering Post-MI Agarwal, Neha

17 4S p. e61
article
22 Coronary Artery Spasm: Risk Factors and in-Hospital Outcomes Xi, Qianlan

17 4S p. e18
article
23 Coronary Computed Tomographic Angiography as the Initial Gatekeeper Modality to Identify and Assess the Severity of Atherosclerotic Coronary Artery Disease Alam, Loba

17 4S p. e34-e36
article
24 Diagnosis and Management of Familial Dysbetalipoproteinemia in a Patient with Apo E2/E2 Genotype Golwala, Sohil

17 4S p. e28-e29
article
25 Direct Contact of At-Risk Relatives in the United States Identifies Familial Hypercholesterolemia Cases Morgan, Kelly M

17 4S p. e23-e24
article
26 Dried Blood Spot Testing for Cardiovascular Risk Assessment Lang, Maxine

17 4S p. e19
article
27 Effect of Dexamethasone on Modulating Lp(a) Levels in COVID-19 Pneumonia Kukuc, Laura Grace

17 4S p. e6-e7
article
28 † Efficacy and Safety of Evinacumab in Pediatric Patients with Homozygous Familial Hypercholesterolemia Wiegman, Albert

17 4S p. e43-e44
article
29 Equitable Access to Screening and Lipid-Lowering Therapies in a Large Academic Center after Educational Interventions Umer, Muhammad

17 4S p. e14-e15
article
30 † Evaluating the Residual Risk of Recurrent Cardiovascular Events in Contemporary Cardiovascular Outcomes Trials Serge, Korjian

17 4S p. e1-e2
article
31 Evaluation of Lipid, Lipoprotein, and Apolipoprotein Analysis by Nuclear Magnetic Resonance Fernandes, Marianna

17 4S p. e18-e19
article
32 Evinacumab Reduces US Apheresis Eligibility in Patients with Homozygous Familial Hypercholesterolemia Raal, Fredrick J

17 4S p. e44
article
33 Exploring Prevalence of Statin Intolerance in Patients on LDL-Lowering Therapy Using Epic Baecher, Naz

17 4S p. e21
article
34 Familial LCAT (Lecithin: Cholesterol Acyltransferase) Deficiency: A Case Report Alfaro, Gregory

17 4S p. e25-e26
article
35 Following a Hunch: Diagnosis of Familial Hypercholesterolemia in a Patient with Severe Hypertriglyceridemia Modarressi, Taher

17 4S p. e11
article
36 Genetic and Metabolic Determinants of Lipoprotein(a) Stewart, Sarah L

17 4S p. e5-e6
article
37 Genetic Variants in Patients with Persistent, Severe Hypertriglyceridemia Bernstein, Donna L.

17 4S p. e32-e33
article
38 † Higher Cardiovascular Event Rates for High-Risk Americans Who Did Not Meet 2018 Multidisciplinary Guideline on the Management of Blood Cholesterol Thresholds Myers, Kelly D

17 4S p. e5
article
39 Improvement in Cognitive Function and Reducing the Risk of Developing Cardiovascular Events/ Stroke in Homocysteinemia Gabrah, Kirollos

17 4S p. e27-e28
article
40 ⁎ Incidental Coronary Calcium on Non-Gated CT Scans of the Chest: A Stepwise Approach to Addressing Underreporting and Implementing Deep Learning Grant, Jelani K.

17 4S p. e37-e38
article
41 Incident Type 2 Diabetes (T2D) Following Statin Initiation in Youth Webster, Gabriella Elizabeth Zaruba

17 4S p. e41-e42
article
42 † Investigating Hepatocyte Cholesterol Uptake Ex Vivo Following CSL112 (Apolipoprotein A-I [Human]) Infusion in Post Myocardial Infarction Patients Velkoska, Elena

17 4S p. e34
article
43 Lifestyle Intervention in Primary Care Patients with Metabolic Syndrome Shackelford, Sommer

17 4S p. e49
article
44 Lipid Goals Achievement in Secondary Cardiovascular Prevention: Predictors of Success in a Large Multicentre Cohort Study in Greece Paparodis, Rodis D.

17 4S p. e46
article
45 Lipid Goals Achievement in Secondary Cardiovascular Prevention: Predictors of Success in a Large Multicentre Cohort Study in Greece Paparodis, Rodis D.

17 4S p. e47
article
46 Lipid lowering Effect of Dapagliflozin Alone versus Dapagliflozin- Saxagliptin Combination in Type 2 Diabetes (T2DM) Subjects Sen, Sabyasachi

17 4S p. e48
article
47 Lipoprotein(a): Mirroring Familial Hypercholesterolemia Parvathinathan, Lakshmi

17 4S p. e10
article
48 Lipoprotein X - In Graft vs. Host Disease Vedamurthy, Deepak

17 4S p. e10-e11
article
49 † Lomitapide Hepatic Safety: A Long-Term Retrospective Analysis in Patients with Homozygous Familial Hypercholesterolaemia Larrey, Dominique

17 4S p. e31
article
50 Long-Term Efficacy and Safety of Twice-Yearly Inclisiran in Patients with ASCVD and Elevated LDL-C: A Post-Hoc Analysis of ORION-3, a 4-year Open-Label Extension Study Wright, Scott R.

17 4S p. e56-e57
article
51 LP-PLA2 is more Effective at Predicting Elevated CV Risk in Law Enforcement Officers as Compared to Framingham Risk or Coronary Calcium Scoring Sheinberg, Jon

17 4S p. e38
article
52 Management of Dyslipidemia in a Patient with Cerebral Cavernoma Golwala, Sohil

17 4S p. e40-e41
article
53 Medications Are Not Enough: Interdisciplinary Treatment of Familial Chylomicronemia Syndrome in Pregnancy Klahr, Rebecca

17 4S p. e42-e43
article
54 Nuclear Magnetic Resonance Analysis of Serum Amino Acids, General Health Parameters, and Keto-Acids Flowers, Sarah E

17 4S p. e50-e51
article
55 Partial Lysosomal Acid Lipase Deficiency (LAL-D) in Fatty Liver Disease: A Future Role in Preventing Atherosclerosis? Subramanyam, Pritha

17 4S p. e40
article
56 Patients with Diabetes Mellitus and Dyslipidemia Affected by Non-Alcoholic Fatty Liver Disease have higher Mortality and Worse Clinical Outcomes, Nation-Wide Study Khokhlov, Leonid

17 4S p. e53
article
57 Patients with Dyslipidemia and Chronic Kidney Disease Affected by Non-Alcoholic Fatty Liver Disease Have higher Mortality and Worse Clinical Outcomes, Nation-Wide Study Khokhlov, Leonid

17 4S p. e20
article
58 Patients with Dyslipidemia and Heart Failure Affected by Non-Alcoholic Fatty Liver Disease Have higher Mortality and Worse Clinical Outcomes, Nation-Wide Study Khokhlov, Leonid

17 4S p. e20-e21
article
59 Patients with Familial Hypercholesterolemia with Non-Alcoholic Fatty Liver Disease Have Worse Clinical Outcomes, Nation-Wide Study Khokhlov, Leonid

17 4S p. e55
article
60 † Pegozafermin for the Treatment of Severe Hypertriglyceridemia, a Randomized, Double-blind, Placebo-controlled Phase 2 Trial (ENTRIGUE STUDY) Bhatt, Deepak L

17 4S p. e47-e48
article
61 Pegylated-Asparaginase Induced Severe Hypertriglyceridemia in an Adult with Acute B-cell Lymphoblastic Leukemia Acevedo-Mendez, Bernardo Andres

17 4S p. e8
article
62 † Pharmacokinetics of Mibavademab in Healthy Participants: Results from a Randomized, Phase 1, Two-Part, First-in-Human Study Mendell, Jeanne

17 4S p. e58
article
63 Predictors of All-Cause Mortality in Heterozygous Familial Hypercholesterolemia: A Multinational Prospective Study Baass, Alexis Wilfrid

17 4S p. e26-e27
article
64 † Prevalence and Clinical Outcomes of Lipodystrophy: Cross-Sectional Analyses of a US National Cohort Yang, Seonkyeong

17 4S p. e58-e59
article
65 Prevalence of Lipoprotein(a) Measurements in Patients with or at Risk of Cardiovascular Disease Upadhyaya, Bhavana

17 4S p. e17-e18
article
66 Primary Prevention of Stroke is Strongly Correlated with Low-Density-Lipoprotein Cholesterol Reduction: A Meta-Regression Analysis Ghosal, Samit

17 4S p. e38-e39
article
67 ⁎ Racial Disparities in Access to Coronary Calcium Scoring and Downstream Cardiovascular Care and Events Umer, Muhammad

17 4S p. e14
article
68 Rationale and Design of the Balance Study: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Olezarsen in Patients with Familial Chylomicronemia Syndrome Karwatowska-Prokopczuk, Ewa

17 4S p. e45
article
69 Refractory Hypercholesterolemia in Heterozygous Familial Hypercholesterolemia Treated with Evinacumab Haynes, Tiffany

17 4S p. e26
article
70 Severe Heterozygous Familial Hypercholesterolemia and Elevated Lipoprotein(a): A Double Whammy Parvathinathan, Lakshmi

17 4S p. e8-e9
article
71 Statins and the Risk of Breast, Lung, Colorectal, and Prostate Cancers Vorla, Mounica

17 4S p. e59-e60
article
72 Statin Use After ICH; Is It Safe? A Common but Complex Clinical Scenario under Current Investigation Ambrosino, Maxwell

17 4S p. e9-e10
article
73 Supine Blood Pressure, a Better Predictor of Target Organ Damage than Sitting Blood Pressure Xi, Qianlan

17 4S p. e13-e14
article
74 † Survival into the Eleventh Decade in Persons Receiving Statin Therapy Feeman Jr, William E.

17 4S p. e12
article
75 The Healthy Eating Assessment Tool (HEAT): A Aimplified 10-Point Assessment of CHILD-2 Dietary Compliance for Children with Dyslipidemia Wong, Jonathan Peter

17 4S p. e42
article
76 The Outcome of Percutaneous Coronary Intervention in Patients with Familial Hypercholesterolemia: A Nationwide Analysis Amoah, Joseph Kofi

17 4S p. e30
article
77 The Outcome of Percutaneous Coronary Intervention in Patients with Metabolic Syndrome: A Nationwide Analysis Amoah, Joseph Kofi

17 4S p. e52-e53
article
78 The Outcome of Percutaneous Coronary Intervention in Prediabetes Patients: A Nationwide Analysis Amoah, Joseph Kofi

17 4S p. e52
article
79 The Prediction and Prevention of Diabetes Mellitus Schaefer, Ernst J

17 4S p. e51
article
80 † The Vast Majority of High- and Very-High Risk Hypercholesterolemia Patients Never Reach below LDL-C Thresholds in the 2018 ACC/AHA Guidelines Wilemon, Katherine A

17 4S p. e4-e5
article
81 Timing of PCSK9i Initiation and Its Relationship with Clinical Outcomes in US Patients with Prior Cardiovascular Events: A Claims Database Analysis Martinez, Laura

17 4S p. e44-e45
article
82 Treatment Target Achievement in Patients with Familial Hypercholesterolemia: A Real-World Descriptive Study Baass, Alexis Wilfrid

17 4S p. e4
article
83 Trends in Lipoprotein(a) Testing at the University of Pennsylvania Health Systems from 2012-2021 Bajaj, Archna

17 4S p. e3-e4
article
84 † Triglyceride Patterns among Patients in US Clinical Practice Kutrieb, Emily

17 4S p. e60-e61
article
85 Underutilization of Guideline-Recommended Genetic Testing to Diagnose Familial Hypercholesterolemia in a Large, Real-world Cohort Ward, Andrew

17 4S p. e31-e32
article
86 Usefulness of the ApoB Quick Diagnosis App in the Diagnosis of Suspected Familial Chylomicronemia Syndrome Kukuc, Laura Grace

17 4S p. e27
article
87 ^† Using Healthcare Claims Data and Machine Learning to Identify Health Disparities for Individuals with Familial Hypercholesterolemia Ahmad, Zahid

17 4S p. e16
article
88 Using Virtual Reality and Other Immersive Tools to increase HCPs Ability to Differentially Diagnose and Manage FH Welch, Lauren

17 4S p. e45-e46
article
89 *! Very-High-Risk Atherosclerotic Cardiovascular Disease Status Among Patients with CAC >1000: Implications for Intensive Lipid-Lowering Therapy Razavi, Alexander C.

17 4S p. e12-e13
article
                             89 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands